OUR FOCUS IS TO HELP FOUNDERS GO FURTHER
Since 2015, RYSE is one of Europe’s leading healthtech investors with a ground-breaking approach to selecting and rapidly scaling early-stage healthtech companies.
RYSE Asset Management LLP (RYSE), registered in England and Wales, is authorised and regulated by the Financial Conduct Authority having Firm Reference Number 519070.
